Proteomics Market by Instrument (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation, and Other), Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, and Protein Fractionation Reagents), Services and Software (Services and Software), Application (Clinical Diagnostics, Drug Discovery, and Other): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026483 | Pages: 100 | Industry: Biotechnology | Date: Sep 2022 | Type: Global

The market crossed the US$ 29.69 billion mark in 2022 and is expected to hit US$ 69.86 billion by 2030, recording a CAGR of 10.8% during the forecast period

The proteomics market has been significantly growing with the increasing demand for personalized medicine

Personalized medicines are an effective treatment and promising approach against cancer, rare genetic conditions, and neurodegenerative diseases. The advancements in proteomic research have contributed to the development of personalized medicines by expediting the detection of protein biochips, protein biomarkers, and proteomics-based molecular diagnostics. Personalized medicine is prescribed in cancer according to genetic modification and provides information about a patient's tumor profiling and treatment plan. The progress of proteomics in achieving personalized therapy has been possible due to tremendous advancements in protein interactions, protein expression patterns, modifications, and translation techniques.

Within the report, the market is segmented into instruments, reagents, services and software, application, and geography. Based on instruments, the global proteomics market is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, x-ray crystallography, surface plasmon resonance, protein fractionation, and others. Based on reagents, the market is segmented into immunoassay reagents, spectroscopy reagents, chromatography reagents, protein microarray reagents, x-ray crystallography reagents, electrophoresis reagents, and protein fractionation reagents. Based on services and software, the market is bifurcated into services and software. Based on application, the market is segmented into clinical diagnostics, drug discovery, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Analytical protein microarray is a far-reaching technology that will empower the growth of the market

Antibody microarray is the most representative class of analytical protein microarray. After antibody capture, proteins are detected by direct protein labeling. These are typically used to measure proteins' expression levels and binding affinities. Antibody arrays are also used for protein profiling of bladder cancer. Microarray immunoassays detect Staphylococcal enterotoxin B, cholera toxin, Bacillus globigii, and B. ricin. Analytical and experimental approaches have been developed to identify cellular signaling pathways and characterize the plant kinases through protein microarrays.

The technological advancements in proteomics kit

The proteomics market is projected to grow significantly due to the surging prevalence of genetic diseases. Proteomics is the study of proteomes, which refers to the entire set of proteins produced by a cell or a genome. With the increase in research, the technical and monetary field is expected to incorporate technologies that will apply to tissue samples and serum for extracting biological information to aid scientists and clinicians in understanding the dynamic biology of cancer patients. Several instrumentation technologies are used in the field, which include surface plasmon resonance (SPR) systems, spectroscopy, protein microarrays, chromatography, X-ray crystallography, electrophoresis, and protein fractionation systems. For instance, Bruker launched a novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging.

Recent strategic developments in the proteomics market

The proteomics market has undergone several significant developments, and a few of these have been mentioned below:

  • In Nov 2021, Thermo Fisher Scientific Inc. announced innovative proteomics solutions and a series of co-marketing agreements with industry experts, advancing the throughput, comprehensiveness, and quality of proteomics workflows for applications such as single-cell studies and translational research
  • In January 2022, Bruker expand proteomics strategy with preomics. PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation
  • In June 2021, Bruker Launches timsTOF SCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

The proteomics market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships with Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; Merck KGaA; Agilent Technologies, Inc.; Bruker; Danaher Corporation; GE Healthcare; PerkinElmer, Inc.; Waters Corporation; Illumina, Inc. are among the prominent players operating in the market.

The target audience for the report:

  • Raw material providers
  • Government bodies, such as regulating authorities and policymakers
  • End users
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Instruments:
  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Protein Microarrays
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation
  • Other
  • Reagents:
    • Immunoassay Reagents
    • Spectroscopy Reagents
    • Chromatography Reagents
    • Protein Microarray Reagents
    • X-Ray Crystallography Reagents
    • Electrophoresis Reagents
    • Protein fractionation reagents
  • Services and Software:
    • Services
    • Software
  • Application:
    • Clinical diagnostics
    • Drug discovery
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Bruker
    • Danaher Corporation
    • GE Healthcare
    • PerkinElmer Inc.
    • Waters Corporation
    • Illumina, Inc.

Companies profiled
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Bruker
- Danaher Corporation
- GE Healthcare
- PerkinElmer Inc.
- Waters Corporation
- Illumina, Inc.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000